BioPharma Drive: Drug Pricing
NOVEMBER 11, 2024
Negative drug results cost AbbVie billions of dollars in market value and convinced analysts that Bristol Myers had placed a better bet in buying Karuna Therapeutics.
Drugs.com
NOVEMBER 11, 2024
MONDAY, Nov. 11, 2024 -- The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says.GLP-1 weight-loss drugs like Ozempic or SGLT2 diabetes medications like Jardiance or Farxiga both helped p.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
NOVEMBER 11, 2024
Like the Earth, the Sun likely has swirling polar vortices, according to new research. But unlike on Earth, the formation and evolution of these vortices are driven by magnetic fields.
Drugs.com
NOVEMBER 11, 2024
MONDAY, Nov. 11, 2024 -- Recurring angina chest pain in people with a certain type of heart disease can be tough to treat, but a new hourglass-shaped stent could be a real advance, researchers report.People with what's known as microvascular.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Science Daily: Pharmacology News
NOVEMBER 11, 2024
Why is the expansion of our Universe accelerating? Twenty-five years after its discovery, this phenomenon remains one of the greatest scientific mysteries. Solving it involves testing the fundamental laws of physics, including Albert Einstein's general relativity. Researchers compared Einstein's predictions with data from the Dark Energy Survey. Scientists discovered a slight discrepancy that varies with different periods in cosmic history.
BioPharma Drive: Drug Pricing
NOVEMBER 11, 2024
After an investigation, the agency concluded that a case of muscle weakness in one of Novavax’s trials was actually ALS and unrelated to vaccination.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
BioPharma Drive: Drug Pricing
NOVEMBER 11, 2024
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the brand name Aucatzyl.
Drugs.com
NOVEMBER 11, 2024
MONDAY, Nov. 11, 2024 -- People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.Men with both diabetes and kidney disease will develop heart health problems 28 years earlier than those.
Science Daily: Pharmacology News
NOVEMBER 11, 2024
Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11%, a study shows.
Drugs.com
NOVEMBER 11, 2024
MONDAY, Nov. 11, 2024 -- Americans’ well-being varies widely between different regions of the nation, a new study reports.People in the southern U.S., Appalachia and the Rust Belt states score lowest on the Human Development Index (HDI), a c.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
NOVEMBER 11, 2024
The discovery, centred around controlling tiny hurricanes of light and electromagnetic fields, could revolutionise how much information we can deliver over cables.
Drugs.com
NOVEMBER 11, 2024
MONDAY, Nov. 11, 2024 -- Asthma is associated with memory problems in children, a new study has found. Further, the early onset of asthma might worsen potential memory deficits in kids, researchers found. This is the first study to make such a.
Drug Patent Watch
NOVEMBER 11, 2024
Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.
Drugs.com
NOVEMBER 11, 2024
MONDAY, Nov. 11, 2024 -- Lives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports.Heart disease deaths linked to obesity increased 2.8-fold between 1999 and 2020, according to findings.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Science Daily: Pharmacology News
NOVEMBER 11, 2024
A series of rocks hiding around Colorado's Rocky Mountains may hold clues to a frigid period in Earth's past when glaciers several miles thick covered the entire planet.
FDA Law Blog: Biosimilars
NOVEMBER 11, 2024
By Deborah L. Livornese & JP Ellison — On November 8, 2024, FDA issued a proposed order to remove the oral decongestant ingredient phenylephrine (including both phenylephrine hydrochloride and phenylephrine bitartrate) (collectively, PE) from the OTC monograph on the basis of a lack of effectiveness. FDA also noted that it has concluded that no safety signal was identified for oral PE at doses permitted under the monograph.
Science Daily: Pharmacology News
NOVEMBER 11, 2024
Asthma is associated with memory difficulties in children, and early onset of asthma may exacerbate memory deficits, according to a new study.
Drugs.com
NOVEMBER 11, 2024
MONDAY, Nov. 11, 2024 -- Attention-deficit/hyperactivity disorder can influence a child’s weight in ways that will shape their long-term health, a new study says.Kids with ADHD tend to have lower birth weight, which increases their risk of d.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Science Daily: Pharmacology News
NOVEMBER 11, 2024
A new study on titan arum -- commonly known as the corpse flower for its smell like rotting flesh -- uncovers fundamental genetic pathways and biological mechanisms that produce heat and odorous chemicals when the plant blooms. The study provides insight into the flower's ability to warm up just before blooming through a process known as thermogenesis, an uncommon trait in plants that is not well understood.
BioPharma Drive: Drug Pricing
NOVEMBER 11, 2024
Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two Phase 2 trials.
Science Daily: Pharmacology News
NOVEMBER 11, 2024
A new microscope is capable of live imaging of biological processes in such detail that moving protein complexes are visible.
BioPharma Drive: Drug Pricing
NOVEMBER 11, 2024
The formal denial comes after Cigna CEO David Cordani tried to push back on persistent speculation of a Humana merger earlier this fall.
PPD
NOVEMBER 11, 2024
It is hard to ignore some of the most pressing, long-term trends driving the push to accelerate innovation and progress in drug development. From an aging population increasing health care demand to urgent, unmet medical needs, there are clear drivers to advance safe and effective medicines to patients faster than ever. According to the United Nation’s 2024 World Population Prospects data, the global population of those 65 years old and over will grow from 0.8 billion in 2023 to 1.2 billion in 2
Perficient: Drug Development
NOVEMBER 11, 2024
Join us at the Agentforce World Tour Chicago to discover what AI was meant to be—all in one day, all for free. Experience the groundbreaking AI innovations from Dreamforce, now live in Chicago. Event Details: Date: Thursday, December 19 Time: 9:00 a.m. – 5:00 p.m. ET Location: McCormick Place – Lakeside Center, 2301 S Martin Luther King Dr, Chicago, IL 60616 Registration: Register here.
Drugs.com
NOVEMBER 11, 2024
MONDAY, Nov. 11, 2024 -- You encounter someone collapsed on the sidewalk and quickly dial 911. Whether or not the operator instructs you on how to deliver cardiopulmonary resuscitation (CPR) could mean life or death, especially if the victim is.
Perficient: Drug Development
NOVEMBER 11, 2024
Join us at the Agentforce World Tour Atlanta to be a part of the latest AI innovations from Dreamforce 2024. Engage in sessions and demos to gain hands-on experience and create customized agents tailored to your business needs. This major innovation from Dreamforce is now live in Atlanta. Event Details: Date: Wednesday, December 18 Time: 9:00 a.m. – 5:00 p.m.
Crown Bioscience
NOVEMBER 11, 2024
Introduction to Biomarkers in Drug Development Biomarkers have become a cornerstone in the advancement of modern drug development and precision medicine. A biomarker, short for biological marker, is a measurable indicator of some biological state or condition. These can be proteins, genes, or other molecules that signal an abnormal or normal process in the body.
Perficient: Drug Development
NOVEMBER 11, 2024
We are thrilled to announce that, once again, Perficient has been recognized as a top workplace in the Dallas-Fort Worth region! This honor is presented by The Dallas Morning News in collaboration with Energage and is largely based on feedback from our employees, making it even more significant. Our company culture has played a key role in earning this recognition.
Conversations in Drug Development Trends
NOVEMBER 11, 2024
Jorge Araneta, Senior Director of Technical Delivery at Worldwide, served three years on active duty in the U.S. Navy and an additional four years in the reserves. Watch this interview as he shares his journey transitioning from military service to a career at Worldwide. The post Veterans Day Spotlight: Jorge Araneta’s Transition from the U.S. Navy to a Career at Worldwide appeared first on Worldwide Clinical Trials.
Perficient: Drug Development
NOVEMBER 11, 2024
Visual aids are a powerful tool for improving communication and understanding in healthcare, especially for individuals with cognitive disabilities. By incorporating visual aids into the healthcare environment, providers can help ensure that all patients receive clear, comprehensible information about their health. Here’s how to effectively implement visual aids: The Importance of Visual Aids Visual aids enhance the communication process by providing visual representations of information.
Drug Target Review
NOVEMBER 11, 2024
Immunotherapy has emerged as a powerful tool in our fight against cancer. By mobilising the body’s immune system, this approach offers new hope for patients. However, despite impressive advancements, many patients still do not respond to current immunotherapy treatments. This is partly because cancer cells are shrewd and often develop ways to evade immune detection.
Science Daily: Pharmacology News
NOVEMBER 11, 2024
Research describes a computational model that captures the intricate muscular architecture of an octopus arm.
BioPharma Drive: Drug Pricing
NOVEMBER 11, 2024
Innovation-without-borders philosophy seeks to bring forward only the most promising therapies.
Expert insights. Personalized for you.
126 
Let's personalize your content